JCI - Citations to Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

Citations to this article

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

E M Carvalho, … , T C Jones, W D Johnson Jr

E M Carvalho, … , T C Jones, W D Johnson Jr

Published December 1, 1985
Citation Information: J Clin Invest. 1985;76(6):2066-2069. https://doi.org/10.1172/JCI112209.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1973	Total
Citations:	2	2	1	1	3	2	1	5	3	8	4	7	7	6	12	7	6	5	9	9	10	6	6	5	5	9	12	5	3	5	11	19	11	10	7	7	8	8	3	2	1	253

Citation information

Citations to this article (253)

Title and authors	Publication	Year
T-cell activation and senescence in asymptomatic HIV/Leishmania infantum co-infection de Oliveira Mendes-Aguiar C, do Monte Alves M, Lopes Machado AD, Monteiro GR, Marques Medeiros I, Queiroz JW, Lima ID, Costa EG, Pearson RD, Wilson ME, Glesby MJ, do Nascimento EL, Jerônimo SM	PLOS Neglected Tropical Diseases	2025
Insights to the HIV-associated visceral leishmaniasis clinical outcome: lessons learned about immune mediated disorders Silva-Freitas ML, Corrêa-Castro G, Da-Cruz AM, Santos-Oliveira JR	Frontiers in Immunology	2025
Apolipoprotein E Is Upregulated in Blood and Circulating Monocytes of Indian Patients With Visceral Leishmaniasis. Kausar G, Chauhan SB, Roy R, Kumar S, Engwerda C, Nylen S, Kumar R, Wilson ME, Sundar S	Parasite Immunology	2024
The Immune Memory Response of In Vitro-Polarised Th1, Th2, and Th17 Cells in the Face of Ovalbumin-Transgenic Leishmania major in a Mouse Model Tedla MG, Nahar MF, Every AL, Scheerlinck JP	International Journal of Molecular Sciences	2024
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis Costa CH, Chang KP, Costa DL, Cunha FV	Pathogens	2023
A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases Alimohmmadian MH, Ajdary S, Bahrami F	Iranian Biomedical Journal	2022
Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis DK Goyal, P Keshav, S Kaur	Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases	2021
Whole blood-based in vitro culture reveals diminished secretion of pro-inflammatory cytokines and chemokines in visceral leishmaniasis G Tasew, E Gadisa, A Abera, M Chanyalew, M Abebe, R Howe, U Ritter, A Aseffa, T Laskay	Cytokine	2021
Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis A Magalhães, LP Carvalho, R Costa, MS Pita, TM Cardoso, PR Machado, EM Carvalho, S Arruda, AM Carvalho	International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases	2021
Cytokine profile in Leishmania-positive blood donors A de Oliveira França, LS Soares, MA Pompilio, IA Tozetti, CM Bonin, ME Dorval, HD Schallig	PloS one	2020
Hamster, a close model for visceral leishmaniasis: Opportunities and challenges S Saini, AK Rai	Parasite Immunology	2020
Anti-leishmanial and Anti-inflammatory Agents from Endophytes: A Review RM Toghueo	Natural Products and Bioprospecting	2019
Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice RS Gomes, MV Silva, JC dos Santos, C van Linge, JM Reis, MM Teixeira, SA Pinto, ML Dorta, X Bai, ED Chan, CA Dinarello, MA Oliveira, LA Joosten, F Ribeiro-Dias, JA Appleton	Infection and immunity	2018
Correlates of GLA family adjuvants’ activities SG Reed, D Carter, C Casper, MS Duthie, CB Fox	Seminars in Immunology	2018
CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection EM Carvalho, HG Lacerda, GR Monteiro, JF Rodrigues-Neto, SM Jeronimo, TS Keesen	The American journal of tropical medicine and hygiene	2018
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani MS Duthie, NV Hoeven, Z MacMillen, A Picone, R Mohamath, J Erasmus, FC Hsu, DT Stinchcomb, SG Reed	Frontiers in immunology	2018
Avaliação de IFN-γ e IL-10 em cães naturalmente infectados com Leishmania (Leishmania) chagasi com e sem manifestações clínicas CJ Rosário, MF Dominici, MS Braga, CA Lima, JG Pereira, FA Melo	Pesquisa Veterinária Brasileira	2018
Sera from Visceral Leishmaniasis Patients Display Oxidative Activity and Affect the TNF- α Production by Macrophages In Vitro NM Soares, JN de Souza, TF Leal, EA Reis, MS Miranda, WL Santos, MC Teixeira	BioMed Research International	2017
Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis ML Santos, D Nico, FA de Oliveira, AS Barreto, I Palatnik-de-Sousa, E Carrillo, J Moreno, PM de Luca, A Morrot, DS Rosa, M Palatnik, C Bani-Corrêa, RP de Almeida, CB Palatnik-de-Sousa	Frontiers in immunology	2017
Sera from Visceral Leishmaniasis Patients Display Oxidative Activity and Affect the TNF- α Production by Macrophages In Vitro NM Soares, JN de Souza, TF Leal, EA Reis, MS Miranda, WL Santos, MC Teixeira	BioMed Research International	2017
Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines A Banerjee, P Bhattacharya, AB Joshi, N Ismail, R Dey, HL Nakhasi	Cellular Immunology	2016
Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes A Amit, MR Dikhit, V Mahantesh, R Chaudhary, AK Singh, A Singh, SK Singh, VN Das, K Pandey, V Ali, S Narayan, GC Sahoo, P Das, S Bimal	Journal of Biomolecular Structure and Dynamics	2016
Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation ND Moreira, J Vitoriano-Souza, BM Roatt, PM de Vieira, W Coura-Vital, JM de Cardoso, MT Rezende, HG Ker, RC Giunchetti, CM Carneiro, AB Reis	Parasites & vectors	2016
Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites KA Hofmeyer, MS Duthie, JD Laurance, MA Favila, NV Hoeven, RN Coler, SG Reed, DL Burns	Clinical and vaccine immunology : CVI	2016
A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis S Sharma, RE Davis, S Srivastva, S Nylén, S Sundar, ME Wilson	The Journal of Infectious Diseases	2016
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis P Bhattacharya, R Dey, PK Dagur, AB Joshi, N Ismail, S Gannavaram, A Debrabant, AD Akue, MA KuKuruga, A Selvapandiyan, JP McCoy, HL Nakhasi, CR Engwerda	PLoS neglected tropical diseases	2016
Kala Azar in South Asia E Noiri, TK Jha	Kala Azar in South Asia	2016
Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa A Das, MC Das, N Das, S Bhattacharjee	Pharmaceutical Biology	2016
Leishmania donovani skews the CD56+ Natural Killer T cell response during human visceral leishmaniasis S Kumari, F Jamal, P Shivam, A Thakur, M Kumar, S Bimal, VN Das, K Pandey, S Narayan, AK Gupta, P Das, SK Singh	Cytokine	2015
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE RN Coler, MS Duthie, KA Hofmeyer, J Guderian, L Jayashankar, J Vergara, T Rolf, A Misquith, JD Laurance, VS Raman, HR Bailor, ND Cauwelaert, SJ Reed, A Vallur, M Favila, MT Orr, J Ashman, P Ghosh, D Mondal, SG Reed	IBMS BoneKEy	2015
Genome-Wide Scan for Visceral Leishmaniasis in Mixed-Breed Dogs Identifies Candidate Genes Involved in T Helper Cells and Macrophage Signaling YT Utsunomiya, ÉS Ribeiro, AP Quintal, JR Sangalli, VR Gazola, HB Paula, CM Trinconi, VM Lima, SH Perri, JF Taylor, RD Schnabel, TS Sonstegard, JF Garcia, CM Nunes, DS Zamboni	PloS one	2015
Leishmania vaccine development: exploiting the host–vector–parasite interface SG Reed, RN Coler, D Mondal, S Kamhawi, JG Valenzuela	Expert Review of Vaccines	2015
Elevation of Serum B-Cell Activating Factor Levels During Visceral Leishmaniasis Y Goto, S Omachi, C Sanjoba, Y Matsumoto	The American journal of tropical medicine and hygiene	2014
Dual Immune Modulatory Effect of Vitamin A in Human Visceral Leishmaniasis Bruna L. Lima Maciel, Joanna Gardel Valverde, João Firmino Rodrigues-Neto, Francisco Freire-Neto, Tatjana S. L. Keesen, Selma Maria Bezerra Jeronimo	PloS one	2014
Whole blood assay and visceral leishmaniasis: Challenges and promises OP Singh, S Sundar	Immunobiology	2014
Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis BS Lakshmi, R Wang, R Madhubala	Vaccine	2014
Tr-1-Like CD4+CD25-CD127-/lowFOXP3- Cells Are the Main Source of Interleukin 10 in Patients With Cutaneous Leishmaniasis Due to Leishmania braziliensis DL Costa, TM Cardoso, A Queiroz, CM Milanezi, O Bacellar, EM Carvalho, JS Silva	The Journal of Infectious Diseases	2014
Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals H Kaushal, R Bras-Gonçalves, NS Negi, JL Lemesre, G Papierok, P Salotra	BMC Infectious Diseases	2014
Interleukin 17A Acts Synergistically With Interferon to Promote Protection Against Leishmania infantum Infection MS Nascimento, V Carregaro, DS Lima-Junior, DL Costa, B Ryffel, MS Duthie, A Jesus, RP de Almeida, JS da Silva	The Journal of Infectious Diseases	2014
The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with Leishmania donovani O Rostan, JP Gangneux, C Piquet-Pellorce, C Manuel, AN McKenzie, C Guiguen, M Samson, F Robert-Gangneux	mBio	2013
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis FA de Oliveira, CV Silva, NP Damascena, RO Passos, MS Duthie, JA Guderian, A Bhatia, TR de Moura, SG Reed, RP de Almeida, AR de Jesus	BMC Infectious Diseases	2013
The role of IL15 gene variants in visceral leishmaniasis among Iranian patients M Rasouli, M Kalani, S Kiany	Molecular Biology Reports	2013
Vaccination with Leishmania Hemoglobin Receptor-Encoding DNA Protects Against Visceral Leishmaniasis R Guha, D Gupta, R Rastogi, R Vikram, G Krishnamurthy, S Bimal, S Roy, A Mukhopadhyay	Science Translational Medicine	2013
Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment MS Duthie, J Guderian, A Vallur, A Bhatia, PL Santos, EV de Melo, AR de Jesus, M Todt, D Mondal, R Almeida, SG Reed	European Journal of Clinical Microbiology & Infectious Diseases	2013
To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL-A against Leishmania donovani in BALB/c mice J Joshi, S Kaur	Parasite Immunology	2013
Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients EA Khalil, SA Khidir, AM Musa, BY Musa, ME Elfaki, AM Elkadaru, E Zijlstra, AM El-Hassan	Journal of Tropical Medicine	2013
Asiaticoside induces tumour-necrosis-factor- -mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains SK Bhaumik, J Paul, K Naskar, S Karmakar, T De	Journal of Antimicrobial Chemotherapy	2012
The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice S Chowdhury, T Mukherjee, R Mukhopadhyay, B Mukherjee, S Sengupta, S Chattopadhyay, P Jaisankar, S Roy, HK Majumder	EMBO Molecular Medicine	2012
Immunization with Leishmania Vaccine-Alum-BCG and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey ( Chlorocebus aethiops ) Model: Alum-BCG and Montanide ISA 720 Induces Robust IgG2 JM Mutiso, JC Macharia, MM Gicheru	Scandinavian Journal of Immunology	2012
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood OP Singh, K Gidwani, R Kumar, S Nylén, SL Jones, M Boelaert, D Sacks, S Sundar	Clinical and vaccine immunology : CVI	2012
Leishmania infantum chagasi in Northeastern Brazil: Asymptomatic Infection at the Urban Perimeter NN Pontes, PV Queiroz, RD Pearson, HG Lacerda, JW Queiroz, JL Weirather, SM Jeronimo, ID Lima, DR Martins, JD Barbosa, ME Wilson	The American journal of tropical medicine and hygiene	2012
Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis OP Singh, CB Stober, AK Singh, JM Blackwell, S Sundar, EM Carvalho	PLoS neglected tropical diseases	2012
Role of leptin in human visceral leishmaniasis? A Dayakar, S Chandrasekaran, J Veronica, R Maurya	Medical Hypotheses	2011
Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis S Masih, SK Arora, RK Vasishta	Experimental Parasitology	2011
Advances in Immunology E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné	Advances in Immunology Volume 110	2011
Advances in Parasitology H Huang	Chagas Disease, Part A	2011
New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas KM Dupnik, EL Nascimento, JF Rodrigues-Neto, T Keesen, MZ Fernandes, I Duarte, SM Jeronimo	Drug Development Research	2011
Nonviral Infections VA Alves, E Abdalla	Practical Hepatic Pathology A Diagnostic Approach	2011
In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection BA Pereira, FS Silva, KM Rebello, M Marín-Villa, YM Traub-Cseko, TC Andrade, ÁL Bertho, ER Caffarena, CR Alves	BMC Immunology	2011
Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study K Gidwani, S Jones, R Kumar, M Boelaert, S Sundar, PA Bates	PLoS neglected tropical diseases	2011
Evidence That Lipopolisaccharide May Contribute to the Cytokine Storm and Cellular Activation in Patients with Visceral Leishmaniasis JR Santos-Oliveira, EG Regis, CR Leal, RV Cunha, PT Bozza, AM Da-Cruz, EM Carvalho	PLoS neglected tropical diseases	2011
Th1/Th2 Cytokine Profile in Patients Coinfected with HIV and Leishmania in Brazil MZ Rodrigues, MF Grassi, S Mehta, XQ Zhang, LL Gois, RT Schooley, R Badaro	Clinical and vaccine immunology : CVI	2011
KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis Y Goto, A Bhatia, VS Raman, H Liang, R Mohamath, AF Picone, SE Vidal, TS Vedvick, RF Howard, SG Reed	Clinical and vaccine immunology : CVI	2011
Control of Innate and Adaptive Immune Responses during Infectious Diseases J Aliberti		2011
‘Active chronic visceral leishmaniasis’ in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients N Bourgeois, P Bastien, J Reynes, A Makinson, I Rouanet, L Lachaud	HIV Medicine	2010
Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis H Daneshvar, MM Molaei, H Kamiabi, R Burchmore, P Hagan, RS Phillips	Parasite Immunology	2010
Plasma lipoproteins in visceral leishmaniasis and their effect onLeishmania-infected macrophages NM Soares, TF Leal, MC Fiúza, EA Reis, MA Souza, WL Dos-Santos, L Pontes-De-Carvalho	Parasite Immunology	2010
Human immunodeficiency virus and leishmaniasis N Ezra, MT Ochoa, N Craft	Journal of global infectious diseases	2010
Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine R Kumar, Y Goto, K Gidwani, KD Cowgill, S Sundar, SG Reed	The American journal of tropical medicine and hygiene	2010
Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis R Nagill, S Kaur	Vaccine	2010
A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy S Mondal, P Bhattacharya, M Rahaman, N Ali, RP Goswami, P Sinnis	PLoS neglected tropical diseases	2010
Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases TA Patel, DN Lockwood	Tropical Medicine & International Health	2009
Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis R Nagill, R Mahajan, M Sharma, S Kaur	Parasitology International	2009
Immunoactivation and immunopathogeny during active visceral leishmaniasis H Goto, MG Prianti	Revista do Instituto de Medicina Tropical de São Paulo	2009
Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis M Samant, R Gupta, S Kumari, P Misra, P Khare, PK Kushawaha, AA Sahasrabuddhe, A Dube	Journal of immunology (Baltimore, Md. : 1950)	2009
IFN-β Impairs Superoxide-Dependent Parasite Killing in Human Macrophages: Evidence for a Deleterious Role of SOD1 in Cutaneous Leishmaniasis R Khouri, A Bafica, M da Purificação Pereira Silva, A Noronha, JP Kolb, J Wietzerbin, A Barral, M Barral-Netto, JV Weyenbergh	Journal of immunology (Baltimore, Md. : 1950)	2009
Ubiquitin Conjugation of Open Reading Frame F DNA Vaccine Leads to Enhanced Cell-Mediated Immune Response and Induces Protection against Both Antimony-Susceptible and -Resistant Strains of Leishmania donovani A Sharma, R Madhubala	Journal of immunology (Baltimore, Md. : 1950)	2009
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis J Miret, E Nascimento, W Sampaio, JC França, RT Fujiwara, A Vale, ES Dias, E Vieira, RT da Costa, W Mayrink, AC Neto, S Reed	Vaccine	2008
Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera SK Bhaumik, MK Singh, S Karmakar, T De	Molecular and Biochemical Parasitology	2008
Kinesin Motor Domain of Leishmania donovani as a Future Vaccine Candidate A Dey, P Sharma, NS Redhu, S Singh	Clinical and vaccine immunology : CVI	2008
Immunological and Genetic Evidence for a Crucial Role of IL-10 in Cutaneous Lesions in Humans Infected with Leishmania braziliensis A Salhi, V Rodrigues, F Santoro, H Dessein, A Romano, LR Castellano, M Sertorio, S Rafati, C Chevillard, A Prata, A Alcaïs, L Argiro, A Dessein	Journal of immunology (Baltimore, Md. : 1950)	2008
A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs RC Giunchetti, R Corrêa-Oliveira, OA Martins-Filho, A Teixeira-Carvalho, BM Roatt, RD de Oliveira Aguiar-Soares, W Coura-Vital, RT de Abreu, LC Malaquias, NF Gontijo, C Brodskyn, CI de Oliveira, DJ Costa, M de Lana, AB Reis	Vaccine	2008
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant Y Goto, LY Bogatzki, S Bertholet, RN Coler, SG Reed	Vaccine	2007
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis LP Carvalho, S Passos, O Bacellar, M Lessa, RP Almeida, A Magalhães, WO Dutra, KJ Gollob, P Machado, AR de Jesus	Parasite Immunology	2007
Atypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10 B Rodriguez, R Beatty, A Belli, A Barreto, X Palacios, F Marin, E Harris	Parasite Immunology	2007
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2 S Bossolasco, S Nozza, G Gaiera, A Bestetti, A Lazzarin, P Cinque	AIDS	2007
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani E McFarlane, C Perez, M Charmoy, C Allenbach, KC Carter, J Alexander, F Tacchini-Cottier	Infection and immunity	2007
Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains T Baptista-Fernandes, C Marques, OR Rodrigues, GM Santos-Gomes	Comparative Immunology Microbiology and Infectious Diseases	2007
Immunopathology of Leishmaniasis: An Update P Mansueto, G Vitale, GD Lorenzo, GB Rini, S Mansueto, E Cillari	International journal of immunopathology and pharmacology	2007
IL-10- and TGF-β-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India S Saha, S Mondal, R Ravindran, S Bhowmick, D Modak, S Mallick, M Rahman, S Kar, R Goswami, SK Guha, N Pramanik, B Saha, N Ali	Journal of immunology (Baltimore, Md. : 1950)	2007
Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs RC Giunchetti, R Corrêa-Oliveira, OA Martins-Filho, A Teixeira-Carvalho, BM Roatt, RD de Oliveira Aguiar-Soares, JV de Souza, N das Dores Moreira, LC Malaquias, LL e Castro, M de Lana, AB Reis	Vaccine	2007
Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-? and interleukin-10 and low frequency of tumour necrosis factor-?+monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection V Peruhype-Magalhães, OA Martins-Filho, A Prata, LD Silva, A Rabello, A Teixeira-Carvalho, RM Figueiredo, SF Guimarães-Carvalho, TC Ferrari, JV Weyenbergh, R Correa-Oliveira	Clinical & Experimental Immunology	2006
The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani MF Hassan, Y Zhang, CR Engwerda, PM Kaye, H Sharp, QD Bickle	The American Journal of Pathology	2006
Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis SK Sharma, A Dube, A Nadeem, S Khan, I Saleem, R Garg, O Mohammad	Vaccine	2006
Identification of a novel G245R polymorphism in the IL-2 receptor β membrane proximal domain associated with human visceral leishmaniasis B Bucheton, L Argiro, C Chevillard, S Marquet, MM Kheir, A Mergani, SH El-Safi, AJ Dessein	Genes and Immunity	2006
Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production PT Leopoldo, PR Machado, RP Almeida, A Schriefer, A Giudice, AR de Jesus, JL Ho, LH Guimarães, O Bacellar, EM Carvalho	BMC Infectious Diseases	2006
Genes and environment in susceptibility to visceral leishmaniasis S El-Safi, MM Kheir, B Bucheton, L Argiro, L Abel, J Dereure, JP Dedet, A Dessein	Comptes Rendus Biologies	2006
Estudo comparativo de anticorpos IgG e IgE antileishmania como marcadores de infecção e doença em indivíduos de área endêmica de leishmaniose visceral, em São Luis, MA MD Nascimento, GF de Bezerra, AP Neto, LM da Silva, JM Bezerra, GM de Viana	Revista da Sociedade Brasileira de Medicina Tropical	2006
Inhibition of IL-2 Induced IL-10 Production as a Principle of Phase-Specific Immunotherapy M Bodas, N Jain, A Awasthi, S Martin, RK Loka, D Dandekar, D Mitra, B Saha	Journal of immunology (Baltimore, Md. : 1950)	2006
Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, Mergani A, El-Safi SH, Dessein AJ	Genes and immunity	2006
Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs D Strauss-Ayali, G Baneth, S Shor, F Okano, CL Jaffe	International Journal for Parasitology	2005
INFLUENCE OF PHOSPHOLIPID COMPOSITION ON THE ADJUVANTICITY AND PROTECTIVE EFFICACY OF LIPOSOME-ENCAPSULATED LEISHMANIA DONOVANI ANTIGENS T Mazumdar, K Anam, N Ali	Journal of Parasitology	2005
Induction of Interferon-Gamma (IFN-γ) and T Helper 1 (Th1) Immune Response by Bitter Gourd Extract K IKE, Y UCHIDA, T NAKAMURA, S IMAI	Journal of Veterinary Medical Science	2005
Immunoglobulin G and E responses in various stages of canine leishmaniosis L Iniesta, M Gállego, M Portús	Veterinary Immunology and Immunopathology	2005
Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines SK Arora, NS Pal, S Mujtaba	Experimental Parasitology	2005
Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response R Rosa, OR Rodrigues, C Marques, GM Santos-Gomes	Experimental Parasitology	2005
Balance of IL-10 and Interferon-γ plasma levels in human visceral leishmaniasis: Implications in the pathogenesis A Caldas, C Favali, D Aquino, V Vinhas, J Weyenbergh, C Brodskyn, J Costa, M Barral-Netto, A Barral	BMC Infectious Diseases	2005
Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains of Leishmania donovani That Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis R Basu, S Bhaumik, JM Basu, K Naskar, T De, S Roy	Journal of immunology (Baltimore, Md. : 1950)	2005
Mechanisms of the Natural Reactivity of Lymphocytes from Noninfected Individuals to Membrane-Associated Leishmania infantum Antigens A Sassi, B Larguèche-Darwaz, A Collette, A Six, D Laouini, PA Cazenave, K Dellagi	Journal of immunology (Baltimore, Md. : 1950)	2005
Recombinant Leishmania Antigens for Serodiagnosis of Visceral Leishmaniasis S Passos, LP Carvalho, G Orge, SM Jerônimo, G Bezerra, M Soto, C Alonso, EM Carvalho	Clinical and vaccine immunology : CVI	2005
CD4+ CCR5+ and CD4+ CCR3+ lymphocyte subset and monocyte apoptosis in patients with acute visceral leishmaniasis M Potestio, P D'Agostino, GC Romano, S Milano, V Ferlazzo, A Aquino, GD Bella, R Caruso, G Gambino, G Vitale, S Mansueto, E Cillari	Immunology	2004
A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice T Mazumdar, K Anam, N Ali	Vaccine	2004
Interleukin-15, as Interferon-gamma, Induces the Killing of Leishmania infantum in Phorbol-Myristate-Acetate-Activated Macrophages Increasing Interleukin-12 P D'Agostino, S Milano, F Arcoleo, GD Bella, ML Rosa, V Ferlazzo, R Caruso, N Chifari, G Vitale, S Mansueto, E Cillari	Scandinavian Journal of Immunology	2004
Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study JV Weyenbergh, G Santana, A D'Oliveira, AF Santos, CH Costa, EM Carvalho, A Barral, M Barral-Netto	BMC Infectious Diseases	2004
Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy R Ravindran, K Anam, BC Bairagi, B Saha, N Pramanik, SK Guha, RP Goswami, D Banerjee, N Ali	Infection and immunity	2004
Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters R Garg, N Singh, A Dube	Parasitology	2004
A Major Susceptibility Locus on Chromosome 22q12 Plays a Critical Role in the Control of Kala-Azar B Bucheton, L Abel, S El-Safi, MM Kheir, S Pavek, A Lemainque, AJ Dessein	The American Journal of Human Genetics	2003
Infection of Human Mononuclear Phagocytes and Macrophage-Like THP1 Cells with Leishmania donovani Results in Modulation of Expression of a Subset of Chemokines and a Chemokine Receptor B Dasgupta, K Roychoudhury, S Ganguly, MA Akbar, P Das, S Roy	Scandinavian Journal of Immunology	2003
Characterization of the immune response to Leishmania infantum recombinant antigens LP de Carvalho, M Soto, S Jerônimo, B Dondji, O Bacellar, V Luz, GO Orge, C Alonso, AR Jesus, EM Carvalho	Microbes and Infection	2003
Experimental canine leishmaniasis: evolution of infection following re-challenge with Leishmania infantum GM Santos-Gomes, MJ Capela, J Ramada, L Campino	Acta Tropica	2003
Immunosuppression in Hamsters with Progressive Visceral Leishmaniasis Is Associated with an Impairment of Protein Kinase C Activity in Their Lymphocytes That Can Be Partially Reversed by Okadaic Acid or Anti-Transforming Growth Factor β Antibody A Mookerjee, PC Sen, AC Ghose	Infection and immunity	2003
Immune complex antigens as a tool in serodiagnosis of kala-azar Tapati Chakraborti, Dwijen Sarkar, Dilip K Ghosh	Molecular and Cellular Biochemistry	2003
Alteration of Fas and Fas ligand expression during human visceral leishmaniasis L Eidsmo, D Wolday, N Berhe, F Sabri, I Satti, AM el Hassan, S Sundar, F Chiodi, H Akuffo	Clinical & Experimental Immunology	2002
IL-15 in human visceral leishmaniasis caused by Leishmania infantum S Milano, GD Bella, P D'Agostino, C Barbera, R Caruso, ML Rosa, V Ferlazzo, G Vitale, CL Russa, G Gambino, N Chifari, S Mansueto, E Cillari	Clinical & Experimental Immunology	2002
Cytokine expression during the outcome of canine experimental infection by Leishmania infantum GM Santos-Gomes, R Rosa, C Leandro, S Cortes, P Romão, H Silveira	Veterinary Immunology and Immunopathology	2002
Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis MA Santos, RC Marques, CA Farias, DM Vasconcelos, JM Stewart, DL Costa, CH Costa	Revista da Sociedade Brasileira de Medicina Tropical	2002
Immunoglobulin E Antileishmanial Antibody Response in Cutaneous Leishmaniasis ML Sousa-Atta, GS Salamé, A DOliveira, RP Almeida, AM Atta, EM Carvalho	Clinical and vaccine immunology : CVI	2002
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG A Misra, A Dube, B Srivastava, P Sharma, JK Srivastava, JC Katiyar, S Naik	Vaccine	2001
Leishmania donovani: Evolution and Architecture of the Splenic Cellular Immune Response Related to Control of Infection PC Melby, A Tabares, BI Restrepo, AE Cardona, HS McGuff, JM Teale	Experimental Parasitology	2001
Association analysis of HLA-Class iI and class iII gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis A Meddeb-Garnaoui, S Gritli, S Garbouj, MB Fadhel, RE Kares, L Mansour, B Kaabi, L Chouchane, AB Salah, K Dellagi	Human Immunology	2001
The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response PC Melby, B Chandrasekar, W Zhao, JE Coe	Journal of immunology (Baltimore, Md. : 1950)	2001
Dual Role of the Leishmania major Ribosomal Protein S3a Homologue in Regulation of T- and B-Cell Activation JM Mansfield, A Cordeiro-da-Silva, MC Borges, E Guilvard, A Ouaissi	Infection and immunity	2001
Bronchopulmonary and Mediastinal Leishmaniasis: An Unusual Clinical Presentation of Leishmania donovani Infection BG Marshall, P Kropf, K Murray, C Clark, AM Flanagan, RN Davidson, RJ Shaw, I Muller	Clinical Infectious Diseases	2000
Identification of a 30 kDa antigen from Leishmania (L.) chagasi amastigotes implicated in protective cellular reponses in a murine model AR Pinto, CG Beyrodt, RA Lopes, CL Barbiéri	International Journal for Parasitology	2000
IL-10 AND IL-12 ARE THE MAIN REGULATORY CYTOKINES IN VISCERAL LEISHMANIASIS O Bacellar, A D'oliveira, S Jerônimo, EM Carvalho	Cytokine	2000
The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC) S Gasim, AM Elhassan, A Kharazmi, EA Khalil, A Ismail, TG Theander	Clinical & Experimental Immunology	2000
Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches HW Murray	International Journal of Infectious Diseases	2000
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani: D Wolday, N Berhe, S Britton, H Akuffo	AIDS	2000
Role of CD8+ T cells in endogenous interleukin-10 secretion associated with visceral leishmaniasis BJ Holaday	Memórias do Instituto Oswaldo Cruz	2000
A Novel Leishmania infantum Recombinant Antigen Which Elicits Interleukin 10 Production by Peripheral Blood Mononuclear Cells of Patients with Visceral Leishmaniasis TR Kozel, I Suffia, B Ferrua, X Stien, B Mograbi, P Marty, D Rousseau, K Fragaki, J Kubar	Infection and immunity	2000
TGF-β Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar NA Gomes, CR Gattass, V Barreto-de-Souza, ME Wilson, GA DosReis	Journal of immunology (Baltimore, Md. : 1950)	2000
Les leishmanioses: un modèle d'étude des interactions hôte-parasite; implications pour la maladie humaine H Louzir, K Dellagi	Annales de l'Institut Pasteur/Actualités	1999
Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis K Kemp, M Kemp, A Kharazmi, A Ismail, JA Kurtzhals, L Hviid, TG Theander	Clinical & Experimental Immunology	1999
Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy K Anam, F Afrin, D Banerjee, N Pramanik, SK Guha, RP Goswami, SK Saha, N Ali	Infection and immunity	1999
TGF-β in infections and infectious diseases SG Reed	Microbes and Infection	1999
T-cell response in human leishmaniasis A Kharazmi, K Kemp, A Ismail, S Gasim, A Gaafar, JA Kurtzhals, AM Hassan, TG Theander, M Kemp	Immunology Letters	1999
The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy J Moreno, J Nieto, C Chamizo, F González, F Blanco, DC Barker, J Alvar	Veterinary Immunology and Immunopathology	1999
Leishmania–HIV Interaction: Immunopathogenic Mechanisms D Wolday, N Berhe, H Akuffo, S Britton	Parasitology Today	1999
Traitement de la leishmaniose viscérale infantile P Minodier, F Faraut-Gambarelli, R Piarroux, C Gire, JM Garnier, H Dumon	Archives de Pédiatrie	1999
T Cell Response of Asymptomatic Leishmania chagasi Infected Subjects to Recombinant Leishmania Antigens SR Costa, AD Júnior, O Bacellar, EM Carvalho	Memórias do Instituto Oswaldo Cruz	1999
A dhfr-ts- Leishmania major Knockout Mutant Cross-protects against Leishmania amazonensis PS Veras, CI Brodskyn, FM Balestieri, LA Freitas, AP Ramos, AR Queiroz, A Barral, SM Beverley, M Barral-Netto	Memórias do Instituto Oswaldo Cruz	1999
Differential Decline in Leishmania Membrane Antigen-Specific Immunoglobulin G (IgG), IgM, IgE, and IgG Subclass Antibodies in Indian Kala-Azar Patients after Chemotherapy SH Kaufmann, K Anam, F Afrin, D Banerjee, N Pramanik, SK Guha, RP Goswami, SK Saha, N Ali	Infection and immunity	1999
Immunoglobulin Subclass Distribution and Diagnostic Value of Leishmania donovani Antigen-Specific Immunoglobulin G3 in Indian Kala-Azar Patients K Anam, F Afrin, D Banerjee, N Pramanik, SK Guha, RP Goswami, PN Gupta, SK Saha, N Ali	Clinical and diagnostic laboratory immunology	1999
Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients M Chatterjee, K Basu, D Basu, D Bannerjee, N Pramanik, SK Guha, RP Goswami, SK Saha, C Mandal	Clinical & Experimental Immunology	1998
Human_Leishmaniasis@cytokines.bahia.br M Barral-Netto, C Brodskyn, EM Carvalho, A Barral	Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.]	1998
Presence of Circulating Levels of Interferon-g, Interleukin-10 and Tumor Necrosis Factor-a in Patients with Visceral Leishmaniasis IM de MEDEIROS, A CASTELO, R SALOMÃO	Revista do Instituto de Medicina Tropical de São Paulo	1998
Human and Murine Immune Responses to a Novel Leishmania major Recombinant Protein Encoded by Members of a Multicopy Gene Family JR Webb, A Campos-Neto, PJ Ovendale, TI Martin, EJ Stromberg, R Badaro, SG Reed	Infection and immunity	1998
Regional Differences in the Cellular Immune Response to Experimental Cutaneous or Visceral Infection with Leishmania donovani PC Melby, YZ Yang, J Cheng, W Zhao	Infection and immunity	1998
Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production J Li, S Sutterwala, JP Farrell	Infection and immunity	1997
Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes F Afrin, N Ali	Infection and immunity	1997
Regulator and effector functions of T-cell subsets in human Leishmanaia infections M Kemp	APMIS	1997
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases DR Lucey, M Clerici, GM Shearer	Clinical microbiology reviews	1996
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation E Murphy, K Shibuya, N Hosken, P Openshaw, V Maino, K Davis, K Murphy, A O'Garra	Journal of Experimental Medicine	1996
VISCERAL LEISHMANIASIS ME Wilson, JA Streit	Gastroenterology Clinics of North America	1996
The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example M Kemp, TG Theander, A Kharazmi	Immunology Today	1996
Histopathology and immunocytochemical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi WL Tafuri, WL Tafuri, AJ Barbosa, MS Michalick, O Genaro, JC França-Silva, W Mayrink, E Nascimento	Revista do Instituto de Medicina Tropical de São Paulo	1996
Subpopulations of T Lymphocytes in the Peripheral Blood, Dermal Lesions and Lymph Nodes of Post Kala-azar Dermal Leishmaniasis Patients MK Ghosh, A Nandy, M Addy, TK Maitra, AC Ghose	Scandinavian Journal of Immunology	1995
Interleukin-4 and Interferon-Gamma Production by Leishmania Stimulated Peripheral Blood Mononuclear Cells from Nonexposed Individuals JA Kurtzhals, M Kemp, LK Poulsen, MB Hansen, A Kharazmi, TG Theander	Scandinavian Journal of Immunology	1995
Immunotherapy with IL-2-stimulated splenocytes reduces in vitro the level of Leishmania donovani infection in peritoneal macrophages Z Eslami, M Olivier, CE Tanner	International Journal for Parasitology	1995
Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy M Ulrich, V Rodriguez, M Centeno, J Convit	Clinical & Experimental Immunology	1995
Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis A Schriefer, A Barral, EM Carvalho, M Barral-Netto	Clinical & Experimental Immunology	1995
A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice ME Wilson, BM Young, KP Andersen, JV Weinstock, A Metwali, KM Ali, JE Donelson	Infection and immunity	1995
Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam GS Nabors, LC Afonso, JP Farrell, P Scott	Proceedings of the National Academy of Sciences	1995
Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania ‘major surface glycoprotein’ (gp63) JO Olobo, CO Anjili, MM Gicheru, PA Mbati, TM Kariuki, JI Githure, DK Koech, WR McMaster	Veterinary Parasitology	1995
Immunologic Response in Pregnancy: Its Role in Endocrine Disorders of Pregnancy and Influence on the Course of Maternal Autoimmune Diseases B Formby	Endocrinology and metabolism clinics of North America	1995
Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen-specific T cell anergy. Ulrich M, Rodriguez V, Centeno M, Convit J	Clinical & Experimental Immunology	1995
Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis. Schriefer A, Barral A, Carvalho EM, Barral-Netto M	Clinical & Experimental Immunology	1995
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral leishmaniasis R Badaró, C Nascimento, JS Carvalho, F Badaró, D Russo, JL Ho, SG Reed, WD Johnson, TC Jones	European Journal of Clinical Microbiology & Infectious Diseases	1994
Cytokines in the treatment of leishmaniasis: From studies of immunopathology to patient therapy JL Ho, R Badaro, D Hatzigeorgiou, SG Reed, WD Johnson	Biotherapy	1994
Dichotomy in the human CD4+T-cell response toLeishmaniaparasites MI Kemp, JØ Kurtzhals, AR Kharazmi, TH Theander	APMIS	1994
Role of cytokines in determining T-lymphocyte function A O'Garra, K Murphy	Current Opinion in Immunology	1994
Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Thl-like response to lipophosphoglycan- associated protein in cells from cured visceral leishmaniasis patients JA Kurtzhals, AS Hey, A Jardim, M Kemp, KU Schaefer, EO Odera, CB Christensen, JI Githure, RW Olafson, TG Theander, A Kharazmi	Clinical & Experimental Immunology	1994
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients AM Elassad, SA Younis, M Siddig, J Grayson, E Petersen, HW Ghalib	Clinical & Experimental Immunology	1994
Evaluation of serum levels of soluble CD4, CD8 and β2-microglobulin in visceral human leishmaniasis G Vitale, C Mocciaro, R Malta, G Gambino, A Spinelli, C Giordano, G Stassi, F Arcoleo, S Milano, E Cillari	Clinical & Experimental Immunology	1994
Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis H Louzir, L Belal-Kachmi, A Sassi, D Laouini, R Ismail, K Dellagi	Clinical & Experimental Immunology	1994
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis GD Miralles, MY Stoeckle, DF McDermott, FD Finkelman, HW Murray	Infection and immunity	1994
Evaluation of serum levels of soluble CD4, CD8 and beta 2-microglobulin in visceral human leishmaniasis G Vitale, C Mocciaro, R Malta, G Gambino, A Spinelli, C Giordano, G Stassi, F Arcoleo, S Milano, E Cillari	Clinical & Experimental Immunology	1994
Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients JA Kurtzhals, AS Hey, A Jardim, M Kemp, KU Schaefer, EO Odera, CB Christensen, JI Githure, RW Olafson, TG Theander	Clinical & Experimental Immunology	1994
Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins YA Skeiky, DR Benson, M Elwasila, R Badaro, JM Burns, SG Reed	Infection and immunity	1994
Natural autoantibodies, IgG antibodies to tetanus toxoid and CD5+ B cells in patients with Mediterranean visceral leishmaniasis. The Leishmania Study Group H Louzir, L Belal-Kacemi, A Sassi, D Laouini, RB Ismail, K Dellagi	Clinical & Experimental Immunology	1994
Parasitic Infections and the Immune System F Kierszenbaum, MB Sztein	Parasitic Infections and the Immune System	1994
Interleukin 12 and the regulation of CD4+ T-cell subset responses during murine Leishmaniasis FP Heinzel	Parasitology Today	1994
Aspects cliniques de la leishmaniose viscérale à l'ère du SIDA A Bourgeade, Y Nosny, S Badiaga	Médecine et Maladies Infectieuses	1994
Treatment of atypical leishmaniasis with interferon ? resulting in progression of Kaposi's sarcoma in an AIDS patient H Albrecht, , G Gross, B Berg, U Helmchen, H Mensing	The Clinical Investigator	1994
Cytokines in the Treatment of Infectious Diseases BJ Kullberg, JW Meer		1994
The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients. Elassad AM, Younis SA, Siddig M, Grayson J, Petersen E, Ghalib HW	Clinical & Experimental Immunology	1994
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma CL Karp, SH el-Safi, TA Wynn, MM Satti, AM Kordofani, FA Hashim, M Hag-Ali, FA Neva, TB Nutman, DL Sacks	Journal of Clinical Investigation	1993
Interleukin 10 production correlates with pathology in human Leishmania donovani infections HW Ghalib, MR Piuvezam, YA Skeiky, M Siddig, FA Hashim, AM el-Hassan, DM Russo, SG Reed	Journal of Clinical Investigation	1993
Potential role for interleukin-10 in the immunosuppression associated with kala azar BJ Holaday, MM Pompeu, S Jeronimo, MJ Texeira, AA Sousa, AW Vasconcelos, RD Pearson, JS Abrams, RM Locksley	Journal of Clinical Investigation	1993
T-cell and cytokine responses in leishmaniasis SG Reed, P Scott	Current Opinion in Immunology	1993
Cytokines in the differentiation of Th1/Th2 CD4+ subsets in leishmaniasis SL Reiner, RM Locksley	Journal of Cellular Biochemistry	1993
Leishmaniases of the New World: current concepts and implications for future research G Grimaldi, RB Tesh	Clinical microbiology reviews	1993
Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis L Morris, AB Troutt, KS McLeod, A Kelso, E Handman, T Aebischer	Infection and immunity	1993
Practical progress and new drugs for changing patterns of leishmaniasis PL Olliaro, AD Bryceson	Parasitology Today	1993
Progress in Clinical Parasitology T Sun		1993
Interferon-gamma in starch microparticles: nitric oxide-generating activity in vitro and antileishmanial effect in mice L Degling, P Stjärnkvist, I Sjöholm	Pharmaceutical Research	1993
Short term treatment of visceral leishmaniasis of the old world with low dose interferon gamma and pentavalent antimony J van Lunzen, J Schmitz, J Brazoska, S Flessenkämper, M Dietrich, P Kern	Infection	1993
The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients G Vitale, G Reina, S Mansueto, R Malta, G Gambino, C Mocciaro, R D'agostino, M Dieli, E Cillari	Clinical & Experimental Immunology	1992
Cytokines and Ly-1 (B1) B Cells A O'garra, M Howard	International Reviews of Immunology	1992
Chemotherapy and immunity in opportunistic parasitic infections in AIDS A Zumla, SL Croft	Parasitology	1992
Histopathology of lymphoid organs in experimental leishmaniasis CE Corbett, RA Paes, MD Laurenti, HF Júnior, MI Duarte	International Journal of Experimental Pathology	1992
Estado atual da leishmaniose cutânea difusa (LCD) no Estado do Maranhão: II. aspectos epidemiológicos, clínico-evolutivos JM Costa, AC Saldanha, AC de Silva, AS Neto, CE Galvão, CM Silva, AR da Silva	Revista da Sociedade Brasileira de Medicina Tropical	1992
Cytokines in Hemopoiesis, Oncology, and AIDS II M Freund, H Link, RE Schmidt, K Welte		1992
Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis EB Corra, JM Cunha, MM Bunn-Moreno, ED Madeira	Zeitschrift für Parasitenkunde	1992
Intracellular Parasites JL Avila, JR Harris		1992
Interferons 1992: How Much of the Promise Has Been Realised? MA Volz, CH Kirkpatrick	Drugs	1992
The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients. Vitale G, Reina G, Mansueto S, Malta R, Gambino G, Mocciaro C, D'Agostino R, Dieli M, Cillari E	Clinical & Experimental Immunology	1992
A Role for CD4+T-Cell Subsets Producing a Selective Pattern of Lymphokines in the Pathogenesis of Human Chronic Inflammatory and Allergic Diseases G Peltz	Immunological Reviews	1991
Variations in susceptibility to Leishmania amazonensis infection in lines of mice selected for high or low immunoresponsiveness R Falcoff, M Barral-Netto, C Stiffel, Y Bouthillier, A Barral, L Freitas, J Mevel, D Mouton	Parasite Immunology	1991
Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients C Meller-Melloul, C Farnarier, S Dunan, B Faugere, J Franck, C Mary, P Bongrand, M Quilici, S Kaplanski	Parasite Immunology	1991
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis FP Heinzel, MD Sadick, SS Mutha, RM Locksley	Proceedings of the National Academy of Sciences	1991
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI P Vieira, R Waal-Malefyt, MN Dang, KE Johnson, R Kastelein, DF Fiorentino, JE deVries, MG Roncarolo, TR Mosmann, KW Moore	Proceedings of the National Academy of Sciences	1991
Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function RM Locksley, P Scott	Immunology Today	1991
CD4+ T-cell subsets: regulation of differentiation and function RL Coffman, TR Mosmann	Research in Immunology	1991
In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease SG Reed, EM Carvalho, CH Sherbert, DP Sampaio, DM Russo, O Bacelar, DL Pihl, JM Scott, A Barral, KH Grabstein	Journal of Clinical Investigation	1990
Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and in NE Reiner, W Ng, CB Wilson, WR McMaster, SK Burchett	Journal of Clinical Investigation	1990
Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma R Badaro, E Falcoff, FS Badaro, EM Carvalho, D Pedral-Sampaio, A Barral, JS Carvalho, M Barral-Netto, M Brandely, L Silva, JC Bina, R Teixeira, R Falcoff, H Rocha, JL Ho, WD Johnson	New England Journal of Medicine	1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus C Montalban, JL Calleja, A Erice, F Laguna, B Clotet, D Podzamczer, J Cobo, J Mallolas, M Yebra, A Gallego	Journal of Infection	1990
Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ production K Zwingenberger, G Harms, C Pedrosa, S Omena, B Sandkamp, S Neifer	Clinical Immunology and Immunopathology	1990
Evasion strategies of Leishmania parasites C Bogdan, M Röllinghoff, W Solbach	Parasitology Today	1990
Peptide Growth Factors and Their Receptors II MB Sporn, AB Roberts		1990
Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated EM Carvalho, O Bacellar, A Barral, R Badaro, WD Johnson	Journal of Clinical Investigation	1989
Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis HW Murray, MJ Oca, AM Granger, RD Schreiber	Journal of Clinical Investigation	1989
Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting PC Melby, FA Neva, DL Sacks	Journal of Clinical Investigation	1989
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets FP Heinzel, MD Sadick, BJ Holaday, RL Coffman, RM Locksley	Journal of Experimental Medicine	1989
Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains OM Ulczak, E Ghadirian, E Skamene, JM Blackwell, PA Kongshavn	Infection and immunity	1989
Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters C Gifawesen, JP Farrell	Infection and immunity	1989
Plasma lipoproteins in infantile visceral Leishmaniasis: deficiency of apolipoproteins A-I and A-II ED Bekaert, R Kallel, ME Bouma, JF Lontie, A Mebazaa, CL Malmendier, M Ayrault-Jarrier	Clinica Chimica Acta	1989
Pharmacology of the Skin I MW Greaves, S Shuster		1989
Immune Response in Chronic Schistosomiasis haematobium and mansoni H Feldmeier, GA Gastl, U Poggensee, AA Daffalla, JA Nogueira-Queiroz, A Capron, HH Peter	Scandinavian Journal of Immunology	1988
Novel 17-kilodalton Leishmania antigen revealed by immunochemical studies of a purified glycoprotein fraction recognized by murine T lymphocytes MM Rodrigues, MT Xavier, L Mendonça-Previato, MA Barcinski	Infection and immunity	1988
Kinetics of gamma interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages NE Reiner, W Ng, T Ma, WR McMaster	Proceedings of the National Academy of Sciences	1988
Leishmania major: Analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice FP Heinzel, MD Sadick, RM Locksley	Experimental Parasitology	1988
Monocytes and Macrophages RB Johnston	New England Journal of Medicine	1988
Phagocytes and Disease MS Klempner, B Styrt, J Ho		1988
Clinical Aspects of Interferons M Revel		1988
A Newly Defined Property of Somatotropin: Priming of Macrophages for Production of Superoxide Anion CK Edwards, SM Ghiasuddin, JM Schepper, LM Yunger, KW Kelley	Science	1988
Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production TB Nutman, V Kumaraswami, EA Ottesen	Journal of Clinical Investigation	1987
Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2 W Solbach, M Lohoff, H Streck, P Rohwer, M Röllinghoff	Immunology	1987
Cellular Immunity in the Joints of Patients with Rheumatoid Arthritis and Other Forms of Chronic Synovitis GS Firestein, V Tsai, NJ Zvaifler	Rheumatic diseases clinics of North America	1987
Macrophage activation: Some questions CF Nathan	Annales de l'Institut Pasteur / Immunologie	1986
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques E Jucker		1986
Tropical Pathology H Spencer, AD Dayan, JB Gibson, RG Huntsman, MS Hutt, GC Jenkins, F Köberle, BG Maegraith, K Salfelder		1973

Advertisement